Search research articles
Contact Us
Filters
Showing results (131-140 of 174) with videos related to
Page
of 18
Sort By:
TH Open : Companion Journal to Thrombosis and Haemostasis
|
February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence
Patricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha
Paolo Pedrazzoli, Antonio Farris, Salvatore Del Prete, et al.
Oncology
|
January 17, 2015
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial
Cora N Sternberg, Fabio Calabrò, Sergio Bracarda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2007
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group
Daniel J Sargent, Smitha Patiyil, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2009
Prospective, multicenter, randomized trial of a new organizational modality for providing information and support to cancer patients
Rodolfo Passalacqua, Caterina Caminiti, Francesco Campione, et al.
JAMA Oncology
|
February 14, 2020
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial
Fausto Petrelli, Roberto Labianca, Alberto Zaniboni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 29, 2024
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts
Julien Taieb, Debora Basile, Jenny Seligmann, et al.
The Oncologist
|
January 17, 2020
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis
Gerardo Rosati, Fabio Galli, Maurizio Cantore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database
Winson Y Cheung, Lindsay A Renfro, David Kerr, et al.
Haematologica
|
September 28, 2019
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer
Cinzia Giaccherini, Marina Marchetti, Giovanna Masci, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 174) with videos related to
Sort By:
Page
of 18
TH Open : Companion Journal to Thrombosis and Haemostasis
|
February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence
Patricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha
Paolo Pedrazzoli, Antonio Farris, Salvatore Del Prete, et al.
Oncology
|
January 17, 2015
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial
Cora N Sternberg, Fabio Calabrò, Sergio Bracarda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2007
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group
Daniel J Sargent, Smitha Patiyil, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2009
Prospective, multicenter, randomized trial of a new organizational modality for providing information and support to cancer patients
Rodolfo Passalacqua, Caterina Caminiti, Francesco Campione, et al.
JAMA Oncology
|
February 14, 2020
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial
Fausto Petrelli, Roberto Labianca, Alberto Zaniboni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 29, 2024
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts
Julien Taieb, Debora Basile, Jenny Seligmann, et al.
The Oncologist
|
January 17, 2020
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis
Gerardo Rosati, Fabio Galli, Maurizio Cantore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database
Winson Y Cheung, Lindsay A Renfro, David Kerr, et al.
Haematologica
|
September 28, 2019
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer
Cinzia Giaccherini, Marina Marchetti, Giovanna Masci, et al.
Page
of 18